Related Experiment Videos
[Monotherapy with antiandrogens for prostatic cancer]
1Urologisk avdeling, Kirurgisk klinikk, Aker sykehus, Oslo.
Summary
Bicalutamide monotherapy offers an effective prostate cancer treatment alternative to castration, maintaining a better quality of life. Patients may experience side effects like breast tenderness but can still respond to castration if bicalutamide fails.
Area of Science:
- Oncology
- Pharmacology
Context:
- Advanced prostate cancer treatment landscape.
- Current treatment options include GnRH agonists and surgical castration.
Purpose:
- To evaluate bicalutamide monotherapy as an alternative to castration for advanced prostate cancer.
- To assess the efficacy and side effect profile of bicalutamide monotherapy.
Summary:
- Bicalutamide monotherapy demonstrates comparable efficacy to castration in advanced prostate cancer.
- It avoids common castration side effects like hot flushes and reduced sexual function.
- Gynaecomastia and breast tenderness are potential side effects requiring patient counseling.
Impact:
- Bicalutamide monotherapy presents a viable first-line treatment option, enhancing patient quality of life.
- It offers a valuable alternative for patients seeking to avoid castration's adverse effects.
- Patients who do not respond to bicalutamide may still benefit from subsequent castration therapy.